Adjuvant treatment in high-risk breast cancer

被引：0
|
作者：
Mansi, JL
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 1996年 / 56卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [11] Adjuvant treatment of high-risk melanoma
    Simon S.C.S.
    Utikal J.
    best practice onkologie, 2021, 16 (7-8) : 308 - 314
  • [12] Breast Cancer Treatment in High-Risk Elderly Patients
    Bano, Razia
    Khan, Iqbal Amina
    Zaidi, Akif Abbas
    Zaidi, Asif Syed Adil
    Khan, Huma Majeed
    Chaudhary, Muhammad Zulqarnain
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : 32 - 32
  • [13] CYCLOPHOSPHAMIDE AND ADRIAMYCIN (C-A) AS ADJUVANT TREATMENT IN BREAST-CANCER PATIENTS AT HIGH-RISK OF METASTASES
    HENDERSON, IC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 108 - 108
  • [14] Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer
    Post, C.
    Mens, J. W.
    Haverkort, M.
    Koppe, F.
    Juergenliemk-Schulz, I.
    Snyers, A.
    Roeloffzen, E.
    Schaake, E.
    Slot, A.
    Stam, T.
    Beukema, J.
    van den Berg, H.
    Lutgens, L.
    Nijman, H.
    de Kroon, C.
    Kroep, J.
    Stiggelbout, A.
    Creutzberg, C.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S206 - S207
  • [15] Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer.
    Martin, Miguel
    Segui, Miguel A.
    Anton, Antonio
    Ruiz, Amparo
    Ramos, Manuel
    Adrover, Encarna
    Aranda, Ignacio
    Rodriguez-Lescure, Alvaro
    Grosse, Regina
    Calvo, Lourdes
    Barnadas, Agusti
    Isla, Dolores
    Martinez del Prado, Purificacion
    Ruiz Borrego, Manuel
    Zaluski, Jerzy
    Arcusa, Angels
    Munoz, Montserrat
    Lopez Vega, Jose M.
    Mel, Jose R.
    Munarriz, Blanca
    Llorca, Cristina
    Jara, Carlos
    Alba, Emilio
    Florian, Jesus
    Li, Junfang
    Lopez Garcia-Asenjo, Jose A.
    Saez, Amparo
    Jose Rios, Maria
    Almenar, Sergio
    Peiro, Gloria
    Lluch, Ana
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2200 - 2210
  • [16] Time to adjuvant chemotherapy in high-risk breast cancer: local outcomes and influences
    Hamid, A.
    White, S.
    BREAST, 2015, 24 : S62 - S62
  • [17] Early intensive and myeloablative adjuvant chemotherapy in women with high-risk breast cancer
    Wörmann, B
    Meden, H
    Riggert, J
    Humpe, A
    Wulf, G
    Koch, B
    Köhler, M
    Kuhn, W
    Hiddemann, W
    ANTICANCER RESEARCH, 1998, 18 (3C) : 2237 - 2241
  • [18] CONCOMITANT ADJUVANT CHEMOTHERAPY AND RADIOTHERAPY FOR HIGH-RISK BREAST-CANCER PATIENTS
    HANSEN, R
    ERICKSON, B
    KOMAKI, R
    JANJAN, N
    COX, J
    WILSON, JF
    ANDERSON, T
    BREAST CANCER RESEARCH AND TREATMENT, 1991, 17 (03) : 171 - 177
  • [19] Adjuvant Radiation Trials for High-Risk Breast Cancer Patients: Adequacy of Lymphadenectomy
    Allan W. Silberman
    Gregory P. Sarna
    Daphne Palmer
    Annals of Surgical Oncology, 2000, 7 : 357 - 360
  • [20] Adjuvant radiation trials for high-risk breast cancer patients: Adequacy of lymphadenectomy
    Silberman, AW
    Sarna, GP
    Palmer, D
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (05) : 357 - 360
12345